furazolidone has been researched along with Gastritis in 15 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the furazolidone-based triple therapy in children with symptomatic H pylori gastritis." | 9.12 | Furazolidone-based triple therapy for H pylori gastritis in children. ( Bonucci, VC; Carelli, AP; Fukushima, E; Kawakami, E; Langner, M; Machado, RS; Ogata, SK; Patricio, FR, 2006) |
| "Seventy-two patients with Helicobacter pylori-associated chronic gastritis were randomized to a 3-week oral treatment with furazolidone 0." | 9.06 | The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori--a randomized double-blind placebo-controlled clinical trial. ( Jiang, SJ; Liu, WZ; Wang, RN; Xia, DH; Xiao, SD; Xu, WW; Zhang, ZH, 1990) |
| "Wei-Yan-Ning and Furazolidone were used separately in the treatment of 62 cases of gastritis and gastric ulcer caused by pyloric campylobacteria." | 7.67 | [Comparative study of the effect of wei-yan-ning and furazolidone in the treatment of gastritis and gastric ulcer caused by pyloric Campylobacter]. ( Song, XR; Zhang, BM, 1989) |
| "To evaluate the furazolidone-based triple therapy in children with symptomatic H pylori gastritis." | 5.12 | Furazolidone-based triple therapy for H pylori gastritis in children. ( Bonucci, VC; Carelli, AP; Fukushima, E; Kawakami, E; Langner, M; Machado, RS; Ogata, SK; Patricio, FR, 2006) |
| "Seventy-two patients with Helicobacter pylori-associated chronic gastritis were randomized to a 3-week oral treatment with furazolidone 0." | 5.06 | The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori--a randomized double-blind placebo-controlled clinical trial. ( Jiang, SJ; Liu, WZ; Wang, RN; Xia, DH; Xiao, SD; Xu, WW; Zhang, ZH, 1990) |
| " Helicobacter pylori status and the histology of the antral and oxyntic mucosa were evaluated in 25 patients with duodenal ulcer treated with a triple schedule of furazolidone, metronidazole and amoxicillin, and in 16 patients treated only with cimetidine." | 3.68 | Histology of the mucosa of gastric antrum and body before and after eradication of Helicobacter pylori. ( Barbosa, AJ; Castro, LP; Coelho, LG; Lima Júnior, GF; Mendes, EN; Oliveira, CA; Passos, MC; Queiroz, DM; Resende, LM; Rocha, GA, 1993) |
| "Wei-Yan-Ning and Furazolidone were used separately in the treatment of 62 cases of gastritis and gastric ulcer caused by pyloric campylobacteria." | 3.67 | [Comparative study of the effect of wei-yan-ning and furazolidone in the treatment of gastritis and gastric ulcer caused by pyloric Campylobacter]. ( Song, XR; Zhang, BM, 1989) |
| "pylori and return to pretreatment levels of gastritis) within 6 wk after cessation of treatment." | 2.66 | Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. The Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities. ( Bender, M; Kraft, W; Morgan, D; Pearson, A, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, S | 1 |
| Chen, H | 1 |
| Huang, K | 1 |
| Jin, D | 1 |
| Zhang, G | 2 |
| Ye, F | 1 |
| Jin, Y | 1 |
| Zhang, S | 1 |
| Pan, J | 1 |
| Yue, M | 1 |
| Yao, D | 1 |
| Wang, Q | 1 |
| Wang, F | 1 |
| Wang, XY | 1 |
| Jia, Y | 1 |
| Shen, SR | 1 |
| Xu, CX | 1 |
| Tang, WL | 1 |
| Liu, SJ | 1 |
| Chen, X | 1 |
| Su, Z | 1 |
| Xu, H | 1 |
| Zhang, C | 1 |
| Shao, S | 1 |
| Li, L | 1 |
| Wang, H | 2 |
| Qiu, G | 1 |
| Kawakami, E | 1 |
| Machado, RS | 1 |
| Ogata, SK | 1 |
| Langner, M | 1 |
| Fukushima, E | 1 |
| Carelli, AP | 1 |
| Bonucci, VC | 1 |
| Patricio, FR | 1 |
| Queiroz, DM | 2 |
| Moura, SB | 1 |
| Mendes, EN | 2 |
| Rocha, GA | 2 |
| Barbosa, AJ | 2 |
| de Carvalho, AS | 1 |
| Long, DS | 1 |
| Li, CM | 1 |
| Yang, QG | 1 |
| Resende, LM | 1 |
| Coelho, LG | 1 |
| Passos, MC | 1 |
| Castro, LP | 1 |
| Oliveira, CA | 1 |
| Lima Júnior, GF | 1 |
| Dong, Q | 1 |
| Liu, W | 1 |
| Zheng, X | 1 |
| Dobrilla, G | 1 |
| Piazzi, L | 1 |
| Amplatz, S | 1 |
| Benvenuti, S | 1 |
| Di Fede, F | 1 |
| Xiao, SD | 1 |
| Liu, WZ | 1 |
| Xia, DH | 1 |
| Jiang, SJ | 1 |
| Wang, RN | 1 |
| Zhang, ZH | 1 |
| Xu, WW | 1 |
| Zhang, BM | 1 |
| Song, XR | 1 |
| Chaĭka, NA | 1 |
| Morgan, D | 1 |
| Kraft, W | 1 |
| Bender, M | 1 |
| Pearson, A | 1 |
| Kasper, G | 1 |
| Dickgiesser, N | 1 |
2 reviews available for furazolidone and Gastritis
| Article | Year |
|---|---|
Helicobacter pylori and gastric ulcer therapy: reflections and uncertainties.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combinatio | 1992 |
[Campylobacter-induced gastritis].
Topics: Antibodies, Bacterial; Campylobacter; Campylobacter Infections; Furazolidone; Gastritis; Humans; Met | 1989 |
7 trials available for furazolidone and Gastritis
| Article | Year |
|---|---|
Comparison of efficacy and safety of ilaprazole and esomeprazole both in initial treatment regimen and retreatment regimen of Helicobacter pylori infection in chronic gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Chronic Disease; Drug Therapy | 2019 |
[Five-day rabeprazole-based triple therapy for helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Clarithromycin; Drug Administrati | 2004 |
Furazolidone-based triple therapy for H pylori gastritis in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Child; Child, Preschool | 2006 |
[Clinical observation on verrucous gastritis with combined therapy of traditional Chinese and Western medicine].
Topics: Adolescent; Adult; Chronic Disease; Cimetidine; Drug Therapy, Combination; Drugs, Chinese Herbal; Fe | 1994 |
Helicobacter pylori and gastric ulcer therapy: reflections and uncertainties.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combinatio | 1992 |
The efficacy of furazolidone and metronidazole in the treatment of chronic gastritis associated with Helicobacter (Campylobacter) pylori--a randomized double-blind placebo-controlled clinical trial.
Topics: Adolescent; Adult; Aged; Chronic Disease; Double-Blind Method; Female; Furazolidone; Gastric Mucosa; | 1990 |
Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. The Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities.
Topics: Adult; Aged; Campylobacter; Campylobacter Infections; Clinical Trials as Topic; Double-Blind Method; | 1988 |
7 other studies available for furazolidone and Gastritis
| Article | Year |
|---|---|
Antibiotic susceptibility guided reuse of levofloxacin-based therapy in a penicillin-allergic patient for Helicobacter pylori infection: A case report.
Topics: Anti-Bacterial Agents; Bismuth; DNA, Bacterial; Drug Hypersensitivity; Drug Resistance, Bacterial; D | 2021 |
Mutations in Helicobacter pylori porD and oorD genes may contribute to furazolidone resistance.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Furazolidone; Gastritis; Gen | 2006 |
Effect of Helicobacter pylori eradication on G-cell and D-cell density in children.
Topics: Adolescent; Amoxicillin; Cell Count; Child; Drug Therapy, Combination; Female; Furazolidone; Gastrin | 1994 |
Histology of the mucosa of gastric antrum and body before and after eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Gastric Mucosa; | 1993 |
[Effect of Helicobacter pylori on gastric epithelial apoptosis].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Apoptosis; Drug Therapy, Combination; Epithel | 1997 |
[Comparative study of the effect of wei-yan-ning and furazolidone in the treatment of gastritis and gastric ulcer caused by pyloric Campylobacter].
Topics: Adolescent; Adult; Campylobacter Infections; Chronic Disease; Drugs, Chinese Herbal; Duodenal Ulcer; | 1989 |
[Clinical significance, epidemiology and laboratory diagnosis of Campylobacter pyloridis].
Topics: Amoxicillin; Antibodies, Bacterial; Biopsy; Bismuth; Campylobacter; Campylobacter Infections; Chroni | 1986 |